SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs EchoSolv AS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

EchoSolv AS

by Echo IQ

AI Verdict

Tool A, SENSICARDIAC MOBI, aids in the initial diagnosis of heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. In contrast, Tool B, EchoSolv AS, specializes in identifying patients at risk for severe aortic stenosis through the analysis of echocardiogram measurements. While both are FDA-cleared AI-powered clinical decision support tools in cardiology, their differing input data and specific diagnostic focus areas make them complementary rather than direct competitors.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if your primary need is real-time, AI-assisted auscultation at the point of care. This tool is ideal for physicians who require immediate support in differentiating between physiological and pathological heart murmurs directly from an electronic stethoscope, aiding in initial diagnostic assessment. It's particularly useful for mobile data capture and display during patient examinations.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose EchoSolv AS if…

Choose EchoSolv AS if your focus is on efficiently identifying patients at high risk for severe aortic stenosis from existing echocardiogram data. This cloud-based platform is best suited for cardiology departments seeking AI-powered clinical decision support to prioritize studies for closer review and streamline the assessment of severe AS probability within their current PACS workflow.

View EchoSolv AS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	EchoSolv AS
Pricing	Contact for pricing	Unknown
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud-based
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

Tool B, EchoSolv AS, offers a more seamless integration into existing clinical workflows as a cloud-based solution that integrates with PACS without requiring EMR integration or additional specialized hardware. In contrast, Tool A, SensiCardiac Mobi, requires a specific mobile device and a user-provided electronic stethoscope, potentially adding complexity to setup and ongoing use. Tool B's ultra-fast risk detection also contributes to higher efficiency in a clinical setting.

Clinical Value

EchoSolv AS

Both tools are FDA-cleared clinical decision support systems. However, EchoSolv AS (Tool B) demonstrates superior and more quantifiable clinical value by identifying severe aortic stenosis with near-perfect accuracy, outperforming traditional clinical interpretation, and reducing missed diagnoses. It also addresses gender bias in diagnosis, offering a significant and impactful improvement in patient outcomes for a critical condition.

Pricing & Value

EchoSolv AS

EchoSolv AS (Tool B) provides greater transparency regarding its pricing model, operating on a subscription basis and actively pursuing and identifying existing reimbursement codes (Miscellaneous Code 93799) with a clear pathway for a dedicated CPT code. This clarity on financial viability and reimbursement significantly enhances its value proposition for healthcare providers. SensiCardiac Mobi (Tool A) offers no public pricing or reimbursement information.

Enterprise Readiness

EchoSolv AS

EchoSolv AS (Tool B) exhibits stronger enterprise readiness due to its cloud-based deployment, explicit integration with PACS, and a proven track record of partnerships with over 41 hospitals and an additional 60 in the integration pipeline. While both are FDA-cleared, HIPAA compliant, and have BAAs, Tool B's established integration capabilities and commercial adoption demonstrate a more mature solution for large healthcare systems.

Innovation

EchoSolv AS

While SensiCardiac Mobi (Tool A) innovates by applying AI to acoustic auscultation for heart murmur diagnosis, EchoSolv AS (Tool B) presents a more advanced and robust application of AI. Tool B analyzes numerical echocardiogram measurements (not images), demonstrates 'real-world readiness' by not relying on variable LVOT measurements, can handle sparse data, and was developed using one of the world's largest echo-linked mortality databases.

Support & Docs

EchoSolv AS

EchoSolv AS (Tool B) provides more documented evidence of comprehensive support and documentation, including a clinician user manual and a suite of supporting documents specifically designed to assist hospitals and clinics with reimbursement processes. While SensiCardiac Mobi (Tool A) likely has user manuals, Tool B's proactive approach to supporting adoption and billing gives it an advantage in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	EchoSolv AS
Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	EchoSolv AS
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Echo IQ
Description	SensiCardiac Mobi is an FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.	EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows.
Primary Function	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals.	Analyzes echocardiograms to identify patients at risk for severe aortic stenosis.
Data Input	Acoustic heart signals from an electronic stethoscope	Numerical measurements from echocardiograms
Key Features (Examples)	Acquires and records acoustic heart signals; Distinguishes between normal/physiological and pathological heart murmurs; Identifies S1, S2, and suspected murmurs.	AI-powered clinical decision support for severe aortic stenosis probability; Consistent severe AS probability and guideline check from measurements; Second reader support to help prioritize studies for closer review.
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Cardiothoracic Surgery

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and EchoSolv AS.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and what are their data input requirements?

SensiCardiac Mobi is a mobile application that acquires and records acoustic heart signals using a user-provided compatible electronic stethoscope at four main auscultation positions, complementing the physician's assessment. EchoSolv AS is designed to fit existing workflows by analyzing numerical measurements from echocardiograms and integrates with PACS, without requiring EMR integration, providing ultra-fast risk detection in under 3 seconds.

What specific clinical conditions and patient populations are targeted by each tool, and which medical specialties would benefit most?

SensiCardiac Mobi assists in diagnosing heart murmurs by differentiating between physiological and pathological sounds, identifying S1, S2, and suspected murmurs, and is applicable across Cardiology, Internal Medicine, and Pediatrics. EchoSolv AS identifies patients at risk for severe aortic stenosis (sAS) by analyzing echocardiograms and is primarily suited for Cardiology and Cardiothoracic Surgery.

What are the key diagnostic capabilities and accuracy claims for each tool in their respective areas?

SensiCardiac Mobi analyzes heart sounds to distinguish between normal/physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs, with studies indicating approximately 92% accuracy in detecting heart abnormalities. EchoSolv AS identifies high-probability severe aortic stenosis patients with high accuracy and efficiency, providing consistent severe AS probability and guideline checks from measurements, with reported sensitivity of 82.2% and specificity of 98.1% in one study.

What is the expected learning curve for physicians to effectively utilize each tool within their practice?

SensiCardiac Mobi operates as a mobile application for capturing heart sounds with an electronic stethoscope, suggesting a relatively intuitive process for physicians already familiar with auscultation. EchoSolv AS is designed to fit existing workflows and uses measurement-based AI from echocardiograms, which may imply a streamlined integration for users familiar with echo analysis, and has been shown to enable novice operators to achieve diagnostic-quality images after one day of AI-guided training in related contexts.

How quickly can a practice expect to realize clinical value or efficiency improvements after implementing each solution?

SensiCardiac Mobi provides immediate analysis of acoustic heart signals from an electronic stethoscope, offering real-time decision support during patient assessment. EchoSolv AS offers ultra-fast risk detection in under 3 seconds and faster clinical review using standardized, measurement-based AI, suggesting rapid efficiency gains in identifying severe AS risk.